Loading...
Evolent Health, Inc.
EVH•NYSE
Healthcare
Medical - Healthcare Information Services
$9.93
$0.58(6.20%)
Evolent Health, Inc. (EVH) Financial Performance & Income Statement Overview
Review Evolent Health, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
30.09%
↑ 30.09%
Operating Income Growth
43.15%
↑ 43.15%
Net Income Growth
45.49%
↑ 45.49%
Operating Cash Flow Growth
-86.84%
↓ 86.84%
Operating Margin
-1.13%
↓ 1.13%
Gross Margin
13.99%
↑ 13.99%
Net Profit Margin
-4.54%
↓ 4.54%
ROE
-10.82%
↓ 10.82%
ROIC
-1.41%
↓ 1.41%
Evolent Health, Inc. (EVH) Income Statement & Financial Overview
Review Evolent Health, Inc.'s (EVH) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $646.54M | $621.40M | $647.14M | $639.65M |
| Cost of Revenue | $570.83M | $540.71M | $570.47M | $565.05M |
| Gross Profit | $75.71M | $80.69M | $76.67M | $74.60M |
| Gross Profit Ratio | $0.12 | $0.13 | $0.12 | $0.12 |
| R&D Expenses | $0.00 | $0.00 | $6.70M | $6.30M |
| SG&A Expenses | $47.70M | $67.06M | $67.22M | $68.78M |
| Operating Expenses | $94.31M | $96.96M | $67.22M | $68.78M |
| Total Costs & Expenses | $665.14M | $637.67M | $637.69M | $633.83M |
| Interest Income | $830000.00 | $794000.00 | $1.37M | $2.55M |
| Interest Expense | $6.72M | $6.01M | $6.00M | $6.00M |
| Depreciation & Amortization | $29.30M | $29.70M | $30.98M | $29.50M |
| EBITDA | $13.29M | $11.96M | $40.44M | $18.79M |
| EBITDA Ratio | $0.02 | $0.02 | $0.06 | $0.03 |
| Operating Income | -$18.60M | -$16.27M | $9.46M | $5.83M |
| Operating Income Ratio | -$0.03 | -$0.03 | $0.01 | $0.009 |
| Other Income/Expenses (Net) | -$5.33M | -$7.49M | -$6.43M | -$3.31M |
| Income Before Tax | -$23.92M | -$23.76M | $1.36M | -$16.71M |
| Income Before Tax Ratio | -$0.04 | -$0.04 | $0.002 | -$0.03 |
| Income Tax Expense | -$1.12M | -$619000.00 | -$238000.00 | $565000.00 |
| Net Income | -$22.80M | -$23.14M | $1.60M | -$17.28M |
| Net Income Ratio | -$0.04 | -$0.04 | $0.002 | -$0.03 |
| EPS | -$0.27 | -$0.27 | -$0.06 | -$0.15 |
| Diluted EPS | -$0.27 | -$0.27 | -$0.06 | -$0.15 |
| Weighted Avg Shares Outstanding | $115.03M | $114.86M | $114.69M | $114.14M |
| Weighted Avg Shares Outstanding (Diluted) | $115.03M | $114.86M | $114.69M | $114.14M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan